Genetic Testing Market Competitive Insights and Precise Outlook 2021 – Bio-Rad Laboratories, Inc. (RainDance Technologies, Inc.), Abbott Laboratories

The Global Genetic Testing Market size is estimated to be USD 9.25 billion in 2019 and is predicted to reach USD 29.44 billion by 2030 with a CAGR of 11.1% from 2020-2030.

Genetic Testing is the study of genetics which is used in the biology or life science for the better understanding of genetic disorders such as sickle cell anemia, Down ’s syndrome and others. This also helps in the development of treatment options for such conditions and also helps in the genetic comparison and development of targeted therapy, personalized medicine and others. Genetic testing can be carried out by using various different techniques, kits, equipments and others.

Access Full Description of this report at:-

https://www.nextmsc.com/report/genetic-testing-market

Top Companies: Bio-Rad Laboratories, Inc. (RainDance Technologies, Inc.), Abbott Laboratories, Novartis International AG, F. Hoffmann-La Roche Ltd., Myriad Genetics, Inc. (Myriad RBM, Inc.), Eurofins Scientific, Danaher Corporation (Cepheid), Illumina, Inc., Thermo Fisher Scientific, Inc. and Qiagen N.V. and others.

Market Dynamics and Trends

The improving and modernizing healthcare infrastructure as well as increased burden of chronic disorders on a global level has proliferated the genetic testing market growth. Furthermore, increased prevalence of genetic disorders coupled with increased awareness about genetic testing and wide applications in healthcare industry are expected to drive the growth of genetic testing market.

The other factors include increased demand of targeted therapy and personalized medicine coupled with increased adoption of personalized medicine and technological advancements are expected to support the market growth. However, stringent regulatory policies with lack of testing standards are also expected to negatively affect the market growth. Moreover, untapped opportunities in the developing economies and strategic developments among market players are also expected to create ample opportunities in genetic testing market over the forecast period.

Request sample copy of this report at:-

https://www.nextmsc.com/genetic-testing-market/request-sample

Market Segmentations and Scope of the Study:

The global genetic testing market share is analyzed on the basis of type, technology, application and geography. On the basis of type, the market is segmented into Predictive Testing, Carrier Testing, Prenatal & Newborn Testing, Diagnostic Testing, Pharmacogenomic Testing, and Others. Based on technology, the market is fragmented into Cytogenetic Testing/ Chromosome Analysis, Biochemical Testing, and Molecular Testing. The molecular testing is sub segmented into DNA Sequencing and Others. On the basis of application, the market is divided into Chromosome Analysis, Genetic Disease Diagnosis, Cardiovascular Disease Diagnosis, and Others. Geographic breakdown and analysis of each of the aforesaid segments includes regions comprising North America, Europe, Asia-Pacific, and RoW.

Geographical Analysis

North America denotes a higher adoption of the genetic testing and is anticipated hold the highest market share during the forecast period. This is attributable to the factors including presence of well-established healthcare amenities, increased prevalence of genetic disorders with increased awareness, and technological advancements.

It is expected that the emerging economies, specifically in the Asia-Pacific region would witness increasing market size owing to increasing accessibility to healthcare facilities in the region, increased public awareness and increased demand of targeted therapy and personalized medicine with increase in disposable increase are also expected to further augment the growth of genetic testing market.

Contact:
Phone Number: +1-217-650-7991
E-mail: info@nextmsc.com

About Next Move Strategy Consulting:

Next Move Strategy Consulting is an independent and trusted third-platform market intelligence provider, committed to deliver high quality, market research reports that help multinational companies to triumph over their competitions and increase industry footprint by capturing greater market share. Our research model is a unique collaboration of primary research, secondary research, data mining and data analytics.

We have been servicing over 1000 customers globally that includes 90% of the Fortune 500 companies over a decade. Our analysts are constantly tracking various high growth markets and identifying hidden opportunities in each sector or the industry. We provide one of the industry’s best quality syndicate as well as custom research reports across 10 different industry verticals. We are committed to deliver high quality research solutions in accordance to your business needs. Our industry standard delivery solution that ranges from the pre consultation to after-sales services, provide an excellent client experience and ensure right strategic decision making for businesses.

For more insights, please visit, https://www.nextmsc.com

This release was published on openPR.